Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 15Breast Neoplasms 13Ovarian Neoplasms 5Stomach Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Uterine Cervical Neoplasms 2Neoplasms 2Melanoma 2Advanced Pancreatic Cancer 2Thoracic Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Lung 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Second Line Treatment of Gastric Cancer 1Sarcoma 1Resectable Biliary Tract Cancer 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Muscle-Invasive Bladder Carcinoma 1Lung Diseases 1HR+/HER2- Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Fulvestrant 5Letrozole 4Capecitabine 3pyrotinib 2Paclitaxel 2Goserelin 2Anastrozole 2palbociclib 1olaparib 1neratinib 1liposomal doxorubicin 1exemestane 1entinostat 1ceralasertib 1capivasertib 1Vinorelbine 1Trastuzumab 1Standard of Care 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Injections 1In Situ Hybridization, Fluorescence 1Immunotherapy, Adoptive 1Gonadotropin-Releasing Hormone 1FCN-437c 1Docetaxel 1Decitabine 1Cyclophosphamide 1Combined Modality Therapy 1Cisplatin 1CYH33 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Breast Cancer × Albumin-Bound Paclitaxel × Clear all
NCT05274893 2022-03-11

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

CSPC Ouyi Pharmaceutical Co., Ltd.

Phase 1 Unknown
28 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡